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Abstract
Background: Over the past ten years, Rapid Diagnostic Tests (RDT) played a major role in improving the use of
biological malaria diagnosis, in particular in poor-resources settings. In Burkina Faso, a recent Demography and
Health Survey (DHS) gave the opportunity to assess the performance of the Paracheck® test in under five children
nationwide at community level.
Methods: A national representative sample of 14,947 households was selected using a stratified two-stage cluster
sampling. In one out of two households, all under five children were eligible to be tested for malaria using both
RDT and microscopy diagnosis. Paracheck® performance was assessed using miscroscopy as the gold standard.
Sensitivity and specificity were calculated as well as the diagnosis accuracy (DA) and the Youden index.
Results: The malaria infection prevalence was estimated at 66% (95% CI: 64.8-67.2) according to microscopy and at
76.2% (95% CI: 75.1-77.3) according to Paracheck®. The sensitivity and specificity were estimated at 89.9% (95% CI:
89.0-90.8) and 50.4% (95% CI: 48.3-52.6) respectively with a Diagnosis Accuracy of 77% and a Youden index of 40%.
The positive predictive value for malaria infection was 77.9% (95% CI: 76.7-79.1) and the negative predictive value
was 72.1% (95% CI: 69.7-74.3). Variations were found by age group, period of the year and urban and rural areas, as
well as across the 13 regions of the country.
Conclusion: While the sensitivity of the Paracheck® test was high, its specificity was poor in the general under five
population of Burkina Faso. These results suggest that Paracheck® is not suitable to assess malaria infection
prevalence at community level in areas with high malaria transmission. In such settings, malaria prevalence in the
general population could be estimated using microscopy.
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Background
In Burkina Faso, malaria is the main cause of consulta-
tions. In 2011, according to statistics from the ministry
of health, this disease was responsible for 61.4% of consul-
tations, 77.7% of hospitalizations, and more than three
quarters (79.8%) of deaths occurring in health facilities
among under five children [1]. Although routine data
from health facilities include presumptive diagnosis and
may be subject to reporting errors, malaria appears to be a
huge burden for individuals, families, and communities in
this country.
Early diagnosis and correct treatment are, therefore, a
major public health need in this country in order to re-
duce morbidity and mortality due to malaria. However,
the lack of laboratory equipment in primary health care
facilities prevents the biological diagnosis of malaria using
microscopy. Clinical diagnosis and presumptive treatment
of fever are the rule, leading to a large proportion of over
diagnosis due to the non-specific symptoms of malaria
[2-5]. In rural Mozambique, in 2008, this proportion was
estimated to range from 30% to 70% [6]. Improper use of
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anti-malarials increases the risk of adverse drug reactions
and the evolution of drug resistance [7]. Drug resistance is
a global issue requiring the development of new effective
treatments [8,9]. Scaling up of artemisinin-based combin-
ation therapy, a more expensive anti-malarial treatment,
also raises concern about the need for biological diagnosis
of malaria.
In the last decade, there has been an increase in the
number of companies manufacturing malaria Rapid Diag-
nosic Tests (RDT). A wide range of field and laboratory
trials have been conducted to assess the accuracy and
effectiveness of RDTs in order to establish their use in
endemic areas [10]. Over the past ten years, these tests
have played a major role in improving the use of bio-
logical malaria diagnosis, in particular in poor-resources
settings [11].
In Burkina Faso, the performance of RDT has been
largely documented in clinical settings [12-19], but no
study has been undertaken nationwide at community
level. A recent Demography and Health Survey (DHS)
included for the first time the use of RDT to detect mal-
aria infection in children under five years of age. Using
these population data, the performance of one of the
most widely used RDT has been assessed nationwide in
the community.
Methods
2010-2011 Demography and Health Survey
Burkina Faso’s fourth DHS was carried out from May
2010 to January 2011 [20]. A national representative sam-
ple of 14,947 households was selected using a stratified
two-stage cluster sampling. In one out of two households,
all under five children, either residents or visitors (i.e.
present in the household the night before the survey),
were eligible to be tested for malaria using both RDT and
microscopy diagnosis. Absentees were revisited to recruit
those missing at the first or second visit. Parents or guard-
ians provided their consent for their child’s participation.
Malaria diagnosis
At the day of the visit, fieldworkers tested children in
their household using a RDT and thick and thin blood
films were used by a laboratory technician to assess mal-
aria infection prevalence by microscopy later.
In Burkina Faso, Plasmodium falciparum accounts for
95% of malaria infections in children less than five years
old [21]. Paracheck® (Orchid Biomedical Systems, Goa,
India), which detects a P. falciparum-specific HRP-2 pro-
tein (PfHRP-2), was used to detect infected children. This
test requires approximately 5 μl of blood and is readable
after 15 minutes.
Blood slides were labelled and air-dried horizontally in
a slide tray. Thin films were fixed with methanol imme-
diately after drying. Slides were stained with 2% Giemsa
for 20 minutes in the field. Later, at the reference labora-
tory (Centre National de Recherche et de Formation sur
le Paludisme) in Ouagadougou, two independent techni-
cians read twice each blood slide and classified them as ei-
ther negative or positive. Another reading was performed
by a third microscopist in case of any discrepancy.
Statistical analysis
Analyses were performed using STATA 12. Prevalence
was reported based on RDT results and microscopy.
Paracheck® performance was assessed using microscopy
as the gold standard. Sensitivity and specificity were cal-
culated as well as the diagnosis accuracy (DA) and the
Youden index. DA is the proportion of true results, ei-
ther positive or negative, among RDT results. It mea-
sures the proportion of correct diagnoses and depends
on the prevalence of the disease. The Youden index (J) is
a function of sensitivity (p) and specificity (q) (J = p + q-1),
is not related to prevalence and is commonly used to
measure diagnostic performance [22-24]. This index ran-
ges between 0 and 1, with values close to 1 indicating that
the performance is relatively large and values close to 0 in-
dicating limited performance.
Results were calculated by age group, urban and rural
areas, region, and month of data collection and period of
the year. Three periods were defined according to the
month of data collection: before the rainy season, in May
and June, during the rainy season, from July to October,
and after the rainy season, from November to January.
Survey procedures in STATA were used to account
for the two-stage cluster sampling as well as the unequal
probability of selection between children in rural and
urban areas due to weighting. Proportions were com-
pared using a Pearson chi-squared test or a Fischer
Exact test. Means were compared using a Student test
or Anova and the correlation between prevalence and
sensibility or specificity was investigated by a Pearson
correlation coefficient.
Results
6,102 children aged from 6 to 59 months were screened
with both Paracheck® test and microscopy during the
study period. There were no differences in the mean age
(p = 0.93) and the sex distribution (p = 0.98) of recruited
children across the 13 regions of the country (Table 1).
Overall, two thirds of the diagnostic tests (62.3%) were
performed during the rainy season and slightly less than
a third (31.8%) after the rainy season (Figure 1). In three
regions – Central-North, Central Plateau and North -
tests were mainly performed after the rainy season (87.3%,
76.4% and 82.4% respectively). Before the rainy season,
only 5.9% of tests were performed, mainly in the Central
region (73.2%).
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Malaria infection prevalence
The overall malaria infection prevalence was estimated
at 66% (95% CI: 64.8-67.2) according to microscopy and
at 76.2% (95% CI: 75.1-77.3) according to Paracheck®.
According to microscopy, the prevalence increased with
age group, from 58.6% in 6 to 12 months old children to
69.7% in 48 to 59 months old children (Table 2). By
period of the year, the prevalence was only 27.0% (95%
CI: 22.0-31.0) before the rainy season while it increased
to 69.9% (95% CI: 68.0-71.0) during the rainy season and
remained similar after the rainy season, 65.0% (95% CI:
63.0-68.0). In rural areas the prevalence was higher than
in urban areas: 73.0% in rural areas versus 18.1% in
Ouagadougou.
The prevalence varied markedly between regions
(Table 3). In the Central region, where tests were mainly
performed before the rainy season, the prevalence was
only 27.6%. Most of regions showed a prevalence ran-
ging between 60 to 70%. The highest prevalence, around
75%, was estimated in five regions – Boucle du Mouhoun,
Central-West, Central-South, South-West and Sahel.
Paracheck® sensitivity and specificity
Tables 2 and 3 summarize Paracheck® performance re-
sults. Overall, the sensitivity and specificity were esti-
mated at 89.9% (95% CI: 89.0-90.8) and 50.4% (95% CI:
Table 1 Children mean age and sex distribution across
the 13 regions of Burkina Faso
Age (months) Boy Girl
Mean ± SD n % n %
Central 32.5 ± 15.3 246 50.0 246 50.0
Boucle du Mouhoun 31.3 ± 14.9 384 51.1 367 48.9
Cascades 32.6 ± 15.5 113 50.2 112 49.8
Central-East 32.3 ± 15.3 252 51.7 235 48.3
Central-North 31.8 ± 14.8 260 50.3 257 49.7
Central-West 32.9 ± 15.5 252 51.7 237 48.5
Centre-South 32.4 ± 15.2 141 53.2 124 46.8
East 32.7 ± 15.4 362 52.6 326 47.4
Hauts Bassins 32.8 ± 15.3 374 50.3 369 49.7
North 31.8 ± 15.9 254 50.9 245 49.1
Central Plateau 31.7 ± 15.4 142 49.7 144 50.3
Sahel 32.0 ± 15.6 262 47.8 286 52.2
South-West 31.5 ± 15.0 139 51.5 131 48.5
Burkina 32.3 ± 15.3 3181 50.8 3079 49.2
Figure 1 Distribution of diagnostic tests by period of the year in the 13 regions.
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Table 2 Prevalence and performance of Paracheck® by age group, month of data collection and area
Microscopy
prevalence
ST + (n) Sensitivity (%) ST- (n) Specificity (%) DA (%) Youden
index (%)
Area
Ouagadougou 18.1 68 80.9 308 73.7 75 55
Small cities 37.2 242 88.0 408 63.7 73 52
Rural areas 73.0 3823 90.2 1411 41.5 77 32
p-value 0.024 <0.001
Age group (months)
6 - 12 58.6 467 89.1 330 54.8 75 44
13 - 23 61.9 775 89.0 478 52.1 75 41
24 - 35 66.0 923 91.2 476 54.2 76 45
36 - 47 70.4 1007 92.3 424 51.7 80 44
48 - 59 69.7 961 87.4 417 49.2 76 37
p-value 0.004 0.10
Month of data collection*
May** 20.0 30 93.3 120 73.3 77 67
June** 31.6 66 83.3 143 69.2 74 53
July 74.0 376 89.6 132 36.4 76 26
August 70.9 795 88.6 327 47.1 76 36
September 73.3 869 88.3 317 44.2 76 32
October 63.4 688 89.5 398 49.5 75 39
November 66.3 838 91.8 426 44.6 76 36
December 64.1 465 93.8 260 59.2 81 53
p-value*** 0.009 <0.001
*Only seven children were tested in January, **Result for the Central region only, ***Comparison between July and December, ST+: positive blood smear test,
ST-: negative blood smear test, DA: Diagnosis accuracy.
Table 3 Prevalence, sensitivity and specificity of Paracheck® across the 13 regions
Microscopy prevalence Paracheck prevalence ST + (n) Sensitivity (%) ST - (n) Specificity (%)
Central 27.6 44.1 136 83.8 356 71.1
Boucle du Mouhoun 77.4 90.7 581 95.4 170 25.3
Cascades 60.0 58.2 135 74.1 90 65.6
Central-East 66.9 76.2 326 90.8 161 53.4
Central-North 68.9 84.5 357 95.0 161 39.1
Central-West 76.3 86.1 373 92.5 116 34.5
Centre-South 75.1 92.8 199 97.5 66 21.2
East 69.1 79.3 475 85.9 212 35.4
Hauts Bassins 59.6 67.6 442 90.0 300 65.3
North 64.1 85.6 320 96.6 179 34.1
Central Plateau 61.0 73.8 175 90.3 112 52.7
Sahel 73.7 64.1 404 74.5 144 65.3
South-West 77.8 85.2 210 95.7 60 50.0
Burkina 66.0 76.2 4133 89.9 2127 50.4
ST+: positive blood smear test; ST-: negative blood smear test.
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48.3-52.6), respectively. The positive predictive value for
malaria infection was 77.9% (95% CI: 76.7-79.1) and the
negative predictive value was 72.1% (95% CI: 69.7-74.3).
By age group, the sensitivity ranged from 89.1% in 6
to 12 months old children to 92.3% in 36 to 47 months
old children and slightly decreased to 87.4% in oldest
children (Table 2). The specificity ranged from 49.2% to
54.8%.
Sensitivity was high during all of the periods of the
study, from 88.3% (95% CI: 81.0-95.6) before the rainy sea-
son to 92.8% (95% CI: 91.3-94.3) after the rainy season.
Sensitivity was slightly higher in rural areas compared to
urban areas. By contrast, specificity did vary markedly by
period of the year and area. The highest specificity was es-
timated to 71.3% (95% CI: 65.6-77.0) before the rainy sea-
son and decreased to 44.3% (95% CI: 41.4-47.2) and 51.9%
(95% CI: 48.1-55.7) during and after the rainy season re-
spectively. Specificity in urban areas was good but de-
creased drastically to 41.5% in rural areas.
A large variation across regions was found. The sensi-
tivity ranged from 74.1% in the Cascades region to
97.5% in the Centre-South region (Table 3). While the
specificity ranged from 21.2% in Centre-South region to
71.1% in the Central region. Figure 2 shows correlation
between the sensitivity and specificity of Paracheck® and
malaria infection prevalence in the 13 regions. No sig-
nificant correlation was found.
Paracheck® diagnosis accuracy and Youden index
Overall the diagnosis accuracy was estimated at 77% and
the Youden index at 40%. The DA did not vary by age
group, period of the year or area (Table 2). By contrast,
the Youden index was estimated at 71% before the rainy
season and dropped to 44% and 52% during and after
the rainy season respectively. By rural and urban areas,
the Youden index was found higher in urban areas: 55%
in Ouagadougou compared to 32% in rural areas.
A large variation across regions was found, the DA
varying from 70% in the East region to 86% in the
South-West region and the Youden index from 21% in
the East to 55% in both Plateau Central and Hauts-
Bassins regions (Figure 3).
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Figure 2 Correlation between sensitivity (A) and specificity (B) of Paracheck® and malaria infection prevalence (microscopy) in the
13 regions.
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Discussion
The 2010 DHS undertaken in Burkina Faso gave the op-
portunity to assess the performance of the Paracheck®
test in under five children nationwide at community
level. Overall, the test showed a high sensitivity (89.9%)
with a low specificity (50.4%) for the detection of malaria
infection. Malaria infection prevalence was high: 66.0%
and 76.2% according to microscopy and Paracheck®
respectively, reflecting an intense transmission of mal-
aria in Burkina Faso, in particular during and after the
rainy season.
In other countries, a few studies were undertaken at
community level. In Tanzania, in an area of intense mal-
aria transmission, Laurent et al. found similar results
with a sensitivity and a specificity of the Paracheck® test
estimated at 96.1% and 63.1% respectively [25]. However,
Figure 3 Diagnosis accuracy (A) and Youden index (B) of Paracheck® in the 13 regions. The diagnosis accuracy (panel A) was quite similar
across areas while the Youden index (panel B) showed large variations across regions.
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in Ethiopia [26] and Angola [27], while transmission of
malaria was low, Pf.HRP-2 RDT showed a low sensitivity,
47.5% and 68.4% respectively, but a high specificity,
98.5% and 92.7% respectively. When the performance is
assessed among symptomatic patients, various studies
reported a higher specificity of Pf HRP-2 tests. A meta-
analysis showed a mean sensitivity of 95% and a mean
specificity of 95.2% [28]. In South-West of Burkina Faso,
the Paracheck® sensitivity and specificity were estimated
at 86% and 90% respectively during the dry season, and
94% and 78% respectively during the rainy season [13].
In the Central-West region, its sensitivity and specificity
were estimated at 100% and 70.9% respectively [29].
Sensitivity results must be interpreted in relation to
parasite density. Indeed, Tiono et al. showed that the
sensitivity of HRP-2 tests increased with increasing para-
site density, from 74.6% when the parasite density was
low (0 to 99/μl) to 99.1% when the parasite density was
higher (1,000 to 4,999/μl) [30]. This result is supported
by other studies using OptiMAL RDT [16] as well as vari-
ous other tests [10]. Although parasite densities were not
available in the 2010 DHS dataset used in this study, these
findings could explain why the Paracheck® sensitivity was
found higher in rural areas, where transmission is higher
than in urban areas, and slightly higher in younger chil-
dren with no or a low level of acquired semi-immunity.
With 50% specificity for the Paracheck® test, about half
of the children with a positive RDT result had a negative
blood slide. This high proportion may be related to the
well-known limitation of Pf HRP-2 tests which detect
persistent HRP-2 antigenicity in the bloodstream for a
few weeks after previous infections [17,25,31]. In addition,
RDTs are known to detect low parasite densities (<100/μL)
[32] which may not be detected by microscopy [33]. Low
parasite densities in asymptomatic carriers are likely to be
common at community level, in particular in endemic
areas. In Senegal, among 8,636 cases of parasitaemia de-
tected in the general population over a four-month follow-
up period during the rainy season, only 4% suffered from
fever [34]. In Burkina Faso, during the study period, an
episode of fever during the two weeks prior to the inter-
view was reported for 20.6% of children [26]. The malaria
infection prevalence being estimated at 66%, this propor-
tion may reflect a relatively large proportion of asymptom-
atic carriers. Before the rainy season or in Ouagadougou,
while the proportion of asymptomatic carriers is likely to
be lower, a highest specificity was found, estimated at
71.3% and 73.7% respectively. Laurent et al. also showed
an increase in specificity with decreasing prevalence [25].
Specificity, as well as positive predictive value, results
should however be interpreted bearing in mind one limi-
tation of this study. Indeed, due to the capacity of the
test to detect both low parasitaemia and persistent HRP2
antigenicity existing at community level, the discordant
cases (positive RDT result/negative microscopy) could not
be classified accurately in the absence of a second gold
standard such as Polymerase Chain Reaction (PCR).
Variations in the sensitivity, specificity and Youden
index were found across the 13 regions of Burkina Faso,
whereas diagnosis accuracy was 70% or above. This is
certainly due to the difference in the distribution of
month of data collection and therefore differences in the
transmission level, prevalence and parasite density. While
tests were mainly performed before the rainy season in
the Centre region, the prevalence was the lowest and the
specificity the highest. In addition, under field condition,
the performance of RDTs may vary from one user to the
other and the quality of the tests may be affected by
temperature, humidity, substandard transport or storage
condition [35].
Conclusion
While the sensitivity of the Paracheck® test was high, its
specificity was poor in the general under five population
of Burkina Faso. These results suggest that Paracheck® is
not suitable to assess malaria infection prevalence at
community level in areas with high malaria transmission.
In such settings, malaria prevalence in the general popula-
tion should be estimated using microscopy. However, in
other countries where elimination of malaria is targeted,
detecting malaria infection at community level, even at
very low parasite density levels, is certainly useful.
Abbreviations
DA: Diagnostic accuracy; DHS: Demography and Health Survey; Pf.HRP-2:
P. falciparum specific HRP-2 protein; PCR: Polymerase chain reaction;
RDT: Rapid diagnostic test; WHO/FIND: World Health Organization/
Foundation for Innovative New Diagnostics.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SS (first author) and FKS conceived the study, performed the statistical
analysis and drafted the manuscript. SS (third author), HT, and FB contributed
to the manuscript by giving substantial intellectual content. IN supervised
the fieldwork and carried out microscopy diagnosis. AR contributed to
intellectual content, supervised the statistical analysis and the writing up of
the manuscript. All authors read and approved the final manuscript.
Author details
1Pôle Epidémiologie et Biostatistique, Institut de Recherche Expérimentale et
Clinique (IREC), Faculté de Santé Publique (FSP), Université catholique de
Louvain (UCL), Clos Chapelle-aux-champs 30, bte B1.30.13, 1200 Bruxelles,
Belgium. 2London School of Hygiene and Tropical Medicine, London, UK.
3Institut de Recherche en Sciences de la Santé (IRSS)/Centre Muraz,
Bobo-Dioulasso, Burkina Faso. 4Centre National de Recherche et de
Formation sur le Paludisme (CNRFP), Ouagadougou, Burkina Faso.
Received: 16 September 2013 Accepted: 17 February 2014
Published: 17 March 2014
References
1. Burkina Faso Ministry of Health: Annuaire Statistique 2011. http://www.sante.
gov.bf/index.php/documents-en-ligne/statistiques-sanitaires.
Samadoulougou et al. Malaria Journal 2014, 13:101 Page 7 of 8
http://www.malariajournal.com/content/13/1/101
2. Dicko A, Mantel C, Kouriba B, Sagara I, Thera MA, Doumbia S, Diallo M,
Poudiougou B, Diakite M, Doumbo OK: Season, fever prevalence and
pyrogenic threshold for malaria disease definition in an endemic area of
Mali. Trop Med Int Health 2005, 10:550–556.
3. Reyburn H, Mbatia R, Drakeley C, Carneiro I, Mwakasungula E, Mwerinde O,
Saganda K, Shao J, Kitua A, Olomi R, Greenwood BM, Whitty CJ:
Overdiagnosis of malaria in patients with severe febrile illness in
Tanzania: a prospective study. BMJ 2004, 329:1212.
4. Scott JA, Berkley JA, Mwangi I, Ochola L, Uyoga S, Macharia A, Ndila C,
Lowe BS, Mwarumba S, Bauni E, Marsh K, Williams TN: Relation between
falciparum malaria and bacteraemia in Kenyan children: a population-
based, case-control study and a longitudinal study. Lancet 2011,
378:1316–1323.
5. Wongsrichanalai C, Barcus MJ, Muth S, Sutamihardja A, Wernsdorfer WH: A
review of malaria diagnostic tools: microscopy and rapid diagnostic test
(RDT). Am J Trop Med Hyg 2007, 77:119–127.
6. Hume JC, Barnish G, Mangal T, Armazio L, Streat E, Bates I: Household cost
of malaria overdiagnosis in rural Mozambique. Malar J 2008, 7:33.
7. Harchut K, Standley C, Dobson A, Klaassen B, Rambaud-Althaus C, Althaus F,
Nowak K: Over-diagnosis of malaria by microscopy in the Kilombero
Valley, Southern Tanzania: an evaluation of the utility and cost-
effectiveness of rapid diagnostic tests. Malar J 2013, 12:159.
8. O’Brien C, Henrich PP, Passi N, Fidock DA: Recent clinical and molecular
insights into emerging artemisinin resistance in Plasmodium falciparum.
Curr Opin Infect Dis 2011, 24:570–577.
9. Strom GE, Haanshuus CG, Fataki M, Langeland N, Blomberg B: Challenges
in diagnosing paediatric malaria in Dar es Salaam, Tanzania. Malar J
2013, 12:228.
10. World Health Organization: Results of WHO Product Testing of Malaria RDTs:
Round 4. http://apps.who.int/iris/bitstream/10665/77748/1/9789241504720_eng.
pdf?ua=1.
11. Ochola LB, Vounatsou P, Smith T, Mabaso ML, Newton CR: The reliability of
diagnostic techniques in the diagnosis and management of malaria in
the absence of a gold standard. Lancet Infect Dis 2006, 6:582–588.
12. Albertini A, Lee E, Coulibaly SO, Sleshi M, Faye B, Mationg ML, Ouedraogo K,
Tsadik AG, Feleke SM, Diallo I, Gaye O, Luchavez J, Bennett J, Bell D: Malaria
rapid diagnostic test transport and storage conditions in Burkina Faso,
Senegal, Ethiopia and the Philippines. Malar J 2012, 11:406.
13. Bisoffi Z, Sirima SB, Menten J, Pattaro C, Angheben A, Gobbi F, Tinto H,
Lodesani C, Neya B, Gobbo M, Van den Ende J: Accuracy of a rapid
diagnostic test on the diagnosis of malaria infection and of
malaria-attributable fever during low and high transmission season in
Burkina Faso. Malar J 2010, 9:192.
14. Bisoffi Z, Sirima SB, Meheus F, Lodesani C, Gobbi F, Angheben A, Tinto H,
Neya B, Van den Ende K, Romeo A, Van den Ende J: Strict adherence to
malaria rapid test results might lead to a neglect of other dangerous
diseases: a cost benefit analysis from Burkina Faso. Malar J 2011, 10:226.
15. Bisoffi Z, Tinto H, Sirima BS, Gobbi F, Angheben A, Buonfrate D, Van den
Ende J: Should malaria treatment be guided by a point of care rapid
test? A threshold approach to malaria management in rural Burkina
Faso. PLoS One 2013, 8:e58019.
16. Diarra A, Nebie I, Tiono A, Sanon S, Soulama I, Ouedraogo A, Gansane A,
Yaro JB, Ouedraogo E, Traore AS, Sirima SB: Seasonal performance of a
malaria rapid diagnosis test at community health clinics in a malaria-
hyperendemic region of Burkina Faso. Parasit Vectors 2012, 5:103.
17. Kattenberg JH, Tahita CM, Versteeg IA, Tinto H, Traore CM, D’Alessandro U,
Schallig HD, Mens PF: Evaluation of antigen detection tests, microscopy,
and polymerase chain reaction for diagnosis of malaria in peripheral
blood in asymptomatic pregnant women in Nanoro, Burkina Faso. Am J
Trop Med Hyg 2012, 87:251–256.
18. Secardin Y, Le BJ: Diagnostic test to identify human Plasmodium species by
the quantitative buffy coat test (in French). Med Trop (Mars) 1999, 59:276–278.
19. Valea I, Tinto H, Nikiema M, Yamuah L, Rouamba N, Drabo M, Guiguemde RT,
D’Alessandro U: Performance of OptiMAL-IT compared to microscopy, for
malaria detection in Burkina Faso. Trop Med Int Health 2009, 14:338–340.
20. Macro international: Measure DHS. http://dhsprogram.com/.
21. Nebie I, Tiono AB, Diallo DA, Samandoulougou S, Diarra A, Konate AT,
Cuzin-Ouattara N, Theisen M, Corradin G, Cousens S, Ouattara AS,
Ilboudo-Sanogo E, Sirima BS: Do antibody responses to malaria vaccine
candidates influenced by the level of malaria transmission protect from
malaria? Trop Med Int Health 2008, 13:229–237.
22. Goddard MJ, Hinberg I: Receiver operator characteristic (ROC) curves and
non-normal data: an empirical study. Stat Med 1990, 9:325–337.
23. Zou KH, Hall WJ, Shapiro DE: Smooth non-parametric receiver operating
characteristic (ROC) curves for continuous diagnostic tests. Stat Med
1997, 16:2143–2156.
24. Zweig MH, Campbell G: Receiver-operating characteristic (ROC) plots: a
fundamental evaluation tool in clinical medicine. Clin Chem 1993, 39:561–577.
25. Laurent A, Schellenberg J, Shirima K, Ketende SC, Alonso PL, Mshinda H,
Tanner M, Schellenberg D: Performance of HRP-2 based rapid diagnostic
test for malaria and its variation with age in an area of intense malaria
transmission in southern Tanzania. Malar J 2010, 9:294.
26. Endeshaw T, Gebre T, Ngondi J, Graves PM, Shargie EB, Ejigsemahu Y,
Ayele B, Yohannes G, Teferi T, Messele A, Zerihun M, Genet A, Mosher AW,
Emerson PM, Richards FO: Evaluation of light microscopy and rapid
diagnostic test for the detection of malaria under operational field
conditions: a household survey in Ethiopia. Malar J 2008, 7:118.
27. Fancony C, Sebastiao YV, Pires JE, Gamboa D, Nery SV: Performance of
microscopy and RDTs in the context of a malaria prevalence survey in
Angola: a comparison using PCR as the gold standard. Malar J 2013,
12:284.
28. Abba K, Deeks JJ, Olliaro P, Naing CM, Jackson SM, Takwoingi Y, Donegan S,
Garner P: Rapid diagnostic tests for diagnosing uncomplicated
P. falciparum malaria in endemic countries. Cochrane Database Syst Rev
2011, 7:CD008122.
29. Maltha J, Guiraud I, Lompo P, Kabore B, Gillet P, Van GC, Tinto H, Jacobs J:
Accuracy of PfHRP2 versus Pf-pLDH antigen detection by malaria rapid
diagnostic tests in hospitalized children in a seasonal hyperendemic
malaria transmission area in Burkina Faso. Malar J 2014, 13:20.
30. Tiono AB, Ouedraogo A, Diarra A, Coulibaly S, Soulama I, Konate AT, Barry A,
Mukhopadhyay A, Sirima SB, Hamed K: Lessons learned from the use of
HRP-2 based rapid diagnostic test in community-wide screening and
treatment of asymptomatic carriers of Plasmodium falciparum in Burkina
Faso. Malar J 2014, 13:30.
31. Ly AB, Tall A, Perry R, Baril L, Badiane A, Faye J, Rogier C, Toure A, Sokhna C,
Trape JF, Michel R: Use of HRP-2-based rapid diagnostic test for Plasmodium
falciparum malaria: assessing accuracy and cost-effectiveness in the villages
of Dielmo and Ndiop, Senegal. Malar J 2010, 9:153.
32. Okell LC, Ghani AC, Lyons E, Drakeley CJ: Submicroscopic infection in
Plasmodium falciparum-endemic populations: a systematic review and
meta-analysis. J Infect Dis 2009, 200:1509–1517.
33. Bell D: Malaria rapid diagnostic tests: one size may not fit all.
Clin Microbiol Rev 2002, 15:771–772.
34. Rogier C, Commenges D, Trape JF: Evidence for an age-dependent
pyrogenic threshold of Plasmodium falciparum parasitemia in highly
endemic populations. Am J Trop Med Hyg 1996, 54:613–619.
35. Eibach D, Traore B, Bouchrik M, Coulibaly B, Coulibaly N, Siby F, Bonnot G,
Bienvenu AL, Picot S: Evaluation of the malaria rapid diagnostic test VIKIA
malaria Ag Pf/Pan in endemic and non-endemic settings. Malar J 2013,
12:188.
doi:10.1186/1475-2875-13-101
Cite this article as: Samadoulougou et al.: Paracheck® rapid diagnostic
test for detecting malaria infection in under five children: a
population-based survey in Burkina Faso. Malaria Journal 2014 13:101.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Samadoulougou et al. Malaria Journal 2014, 13:101 Page 8 of 8
http://www.malariajournal.com/content/13/1/101
